In this post, you will see a wealth of information and my views on CVSC. The reason for this is to respond to some who think that: 1) no recent information on CVSC, 2) CVSC is dead. Well, I try to show that there are reports of 2009 and even somewhat in 2010. So I also try to prove that CVSC not dead. It is very much alive. If not paid advertising, I believe answered an interest. And I think that interest is good. I hope that all information is useful for those interested in knowing CVSC.
Cardiovascular Sciences Inc, (OTC: CSVC), is an R&D stage company with ongoing research in the department of Chemistry at the University of Central Florida. After probing several technologies, one area stood out and 18 months ago, a project was launched. This has already yielded a material that promises to greatly redu…ce the clinically significant morbidity of adhesions that occur following as many as half of all surgeries in both the medical and veterinary fields. The offices of the company currently are located in the Research Park and the company is enrolled in the High-Technology Incubator program at UCF.See MoreFebruary 9, 2009 at 1:14pm ·
written by CEO:
Cardiovascular Sciences, Inc. I want to welcome all of you who are visiting this page and encourage you to sign on as a fan. We are excited about having a Facebook entry and will certainly post new developments for the company as they occur. From time to time, we will also list some exclusive notices on our health related retail site at http://www.rejuven8online.com
We are still located in the Research Park at the University of Central Florida and are still an active client company of UCF’s award winning Technology Incubator. We look forward to ramping back up to full speed our research and development efforts in the area of the prevention of post-surgical adhesions and will utilize our Facebook page and other means to keep everyone informed.
Thank you for your interest and I look forward to interacting with you through Facebook.
Larry Hooper, 2/12/ 2009 8:09
A riddle for smart people, on the splendid future of CVSC. Many well-founded indications that I’ve linked. Only the very smart anticipate the news. You have to read between the lines to remove the hypothesis of what is coming.
Letter to Obama, signed by Larry Hooper, along with the CEOs of the world’s largest companies ( December 2009)
As CEOs of some of the world’s leading technology companies, we have an understanding of the economic
pain being felt today. We are also aware of the promise that lies across the horizon if we are strategic in
our planning. The solutions we offer below are aimed at moving us forward—towards success
CVSC: 10 April 2009
Revision in Authorized Shares
Current issued shares total: 16,964,134
Current share distribution among officers, directors and beneficial owners:
Shares Held % of Issued Shares
Eric Edelmann Executive business consultant 2,418,097 14.3%
Larry Hooper President, CEO and director 5,296,800 31.2%
Jevne Conover Director 3500 <0.1%
Sam Harder Director 3810 <0.1%
John Martin Director 50,500 0.3%
Jim Deinlein Consultant 2,108,200 12.4%
Lawrence H. Hooper, Jr., MD
CEO, Cardiovascular Sciences, Inc.